Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,023.50
-38.10 (-3.59%)
At close: Jun 4, 2025, 3:30 PM IST
Alivus Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| Cash & Equivalents | 712.36 | 3,014 | 2,838 | 5,122 | 1,156 | Upgrade
|
| Short-Term Investments | 4,776 | - | - | 1.11 | 28.05 | Upgrade
|
| Cash & Short-Term Investments | 5,489 | 3,014 | 2,838 | 5,123 | 1,184 | Upgrade
|
| Cash Growth | 82.09% | 6.20% | -44.59% | 332.66% | 1084.25% | Upgrade
|
| Accounts Receivable | 9,697 | 7,654 | 8,068 | 6,735 | 6,195 | Upgrade
|
| Other Receivables | - | 903.68 | 709.4 | 57.94 | 693.69 | Upgrade
|
| Receivables | 9,697 | 8,558 | 8,777 | 6,793 | 6,889 | Upgrade
|
| Inventory | 6,739 | 6,666 | 6,042 | 5,162 | 5,134 | Upgrade
|
| Prepaid Expenses | - | 8.06 | 1.38 | 1.63 | 9.42 | Upgrade
|
| Other Current Assets | 1,426 | 913.88 | 845.01 | 566.28 | 774.08 | Upgrade
|
| Total Current Assets | 23,352 | 19,160 | 18,503 | 17,646 | 13,990 | Upgrade
|
| Property, Plant & Equipment | 10,369 | 8,962 | 8,242 | 6,763 | 5,790 | Upgrade
|
| Long-Term Investments | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | Upgrade
|
| Other Intangible Assets | 199.37 | 148.53 | 180.01 | 103.8 | 79.11 | Upgrade
|
| Other Long-Term Assets | 193.59 | 232.86 | 94.86 | 196.3 | 110.6 | Upgrade
|
| Total Assets | 34,115 | 28,504 | 27,021 | 24,710 | 19,971 | Upgrade
|
| Accounts Payable | 3,905 | 3,687 | 4,272 | 3,077 | 2,213 | Upgrade
|
| Accrued Expenses | 169.57 | 385.91 | 361.1 | 447.76 | 417.55 | Upgrade
|
| Short-Term Debt | - | - | - | - | 9,329 | Upgrade
|
| Current Portion of Leases | 56.48 | 23.87 | 22.65 | 16.8 | - | Upgrade
|
| Current Income Taxes Payable | - | - | 70.78 | 120.03 | 136.93 | Upgrade
|
| Current Unearned Revenue | - | 52.58 | 19.43 | - | - | Upgrade
|
| Other Current Liabilities | 570.9 | 238.76 | 219.21 | 178.19 | 118.2 | Upgrade
|
| Total Current Liabilities | 4,702 | 4,388 | 4,965 | 3,840 | 12,214 | Upgrade
|
| Long-Term Leases | 509.58 | 147.61 | 170.92 | 12.04 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 544.29 | 487.85 | 424.34 | 314.95 | 228.88 | Upgrade
|
| Other Long-Term Liabilities | 185.35 | - | - | - | - | Upgrade
|
| Total Liabilities | 5,941 | 5,181 | 5,639 | 4,167 | 12,443 | Upgrade
|
| Common Stock | 245.07 | 245.05 | 245.05 | 245.05 | 19.6 | Upgrade
|
| Additional Paid-In Capital | - | 10,050 | 10,050 | 10,050 | - | Upgrade
|
| Retained Earnings | - | 12,918 | 11,021 | 10,214 | - | Upgrade
|
| Comprehensive Income & Other | 27,929 | 110.58 | 66.83 | 34.98 | 7,508 | Upgrade
|
| Shareholders' Equity | 28,174 | 23,323 | 21,382 | 20,543 | 7,527 | Upgrade
|
| Total Liabilities & Equity | 34,115 | 28,504 | 27,021 | 24,710 | 19,971 | Upgrade
|
| Total Debt | 566.06 | 171.48 | 193.57 | 28.84 | 9,329 | Upgrade
|
| Net Cash (Debt) | 4,922 | 2,843 | 2,645 | 5,094 | -8,145 | Upgrade
|
| Net Cash Growth | 73.16% | 7.49% | -48.08% | - | - | Upgrade
|
| Net Cash Per Share | 40.06 | 23.17 | 21.58 | 43.34 | -75.55 | Upgrade
|
| Filing Date Shares Outstanding | 122.62 | 122.53 | 122.53 | 122.53 | 107.8 | Upgrade
|
| Total Common Shares Outstanding | 122.62 | 122.53 | 122.53 | 122.53 | 107.8 | Upgrade
|
| Working Capital | 18,650 | 14,772 | 13,538 | 13,806 | 1,776 | Upgrade
|
| Book Value Per Share | 229.77 | 190.35 | 174.51 | 167.66 | 69.82 | Upgrade
|
| Tangible Book Value | 27,974 | 23,175 | 21,202 | 20,439 | 7,448 | Upgrade
|
| Tangible Book Value Per Share | 228.14 | 189.14 | 173.04 | 166.81 | 69.09 | Upgrade
|
| Buildings | - | 3,164 | 3,017 | 2,235 | 2,119 | Upgrade
|
| Machinery | - | 6,273 | 5,743 | 4,426 | 4,129 | Upgrade
|
| Construction In Progress | - | 1,012 | 493.54 | 916.88 | 140.98 | Upgrade
|
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.